Search

everythinglearnresearchcommunity

for

Search:↓

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Some women with PCOS have rare genetic variants linked to the condition.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Skin changes can indicate starvation and nutritional deficiencies in anorexia nervosa.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

AMH levels in adolescents with PCOS are not affected by their weight.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.